| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |